Steven Gilman

Steven Gilman

Director/Board Member at SCYNEXIS, INC.

Net worth: 166 250 $ as of 31/05/2026

73 year
Health Technology
Commercial Services
Consumer Services

Profile

Steven C.
Gilman
is an Independent Director at SCYNEXIS, Inc. since 2015.
Holds Director positions at the Biotechnology Association of Alabama, Massachusetts Society for Medical Research, Inc., PhRMA Foundation, Transcelerate Biopharma, Inc., and Lakes Environmental Association.
Former roles include Vice Chairman at ContraFect Corp.
from 2019 to 2023; Chairman & Chief Executive Officer at ActivBiotics, Inc. from 2006 to 2007; Independent Director at Keryx Biopharmaceuticals, Inc. from 2016 to 2018; Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020; Independent Director at Akebia Therapeutics, Inc. from 2018 to 2026; Independent Director at Vericel Corp.
from 2015 to 2025; Chief Scientific Officer & Executive VP-Research at Cubist Pharmaceuticals LLC from 2010 to 2015; Vice President & General Manager-Inflammation at Millennium Pharmaceuticals, Inc. from 2000 to 2004; Executive Director at Inhibikase Therapeutics, Inc. from 2014 to 2016; Biology Director at Jazz Pharmaceuticals (EUSA Pharma USA), Inc.; Group Director-Global Research & Development at Pfizer (St. Louis); Director at Massachusetts Biotechnology Council, Nextcea, Inc., and other firms; Scientist at Wyeth LLC; Principal at Connecticut College and Temple University School of Medicine; General Manager at Inflammation Research Association, Inc. Education includes undergraduate studies at Miami University and graduate and doctorate degrees from The Pennsylvania State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/06/2025 1,52,830 ( 0.06% ) 155 887 $ 31/05/2026
01/04/2026 14,700 ( 0.02% ) 10 364 $ 31/05/2026

Steven Gilman active positions

CompaniesPositionStart
SCYNEXIS, INC. Director/Board Member 25/02/2015
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member 07/07/2009
Director/Board Member -

Former positions of Steven Gilman

CompaniesPositionEnd
AKEBIA THERAPEUTICS, INC. Director/Board Member 01/04/2026
VERICEL CORPORATION Director/Board Member 30/04/2025
CONTRAFECT CORPORATION Chief Executive Officer 02/04/2019
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Steven Gilman's experience

Training of Steven Gilman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!